Evaluation of Lamotrigine in Subjects With Absence Seizures .
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2018
At a glance
- Drugs Lamotrigine (Primary)
- Indications Absence epilepsy
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 23 Jan 2018 Results assessing the effect of Age-Related Factors on the PK of Lamotrigine and Potential Implications for Dose Optimisation in patients data obtained from NCT00043875, NCT00144872, NCT00113165, NCT00104416, NCT00516139, NCT00264615 published in the Clinical Pharmacokinetics
- 15 Oct 2008 Actual start date changed from Dec 2004 to Nov 2004 as reported by Clinicaltrials.gov.
- 14 Oct 2008 Trial phase changed from III to I as reported by ClinicalTrials.gov.